How late is too late for treatment?

Experiments on mice suggest that an approach called antisense oligonucleotide therapy may be able to treat some symptoms of Angelman syndrome, including problems with epilepsy and sleep.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 Research demonstrates significant advances in patient outcome data
• 2 Study provides new evidence regarding clinical efficacy results
• 3 Findings open new directions for biological mechanism insights

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: